Drugs and Devices

Experimental drug may stop cancer-induced cachexia

Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health, according to a study in the Journal of the National Cancer Institute. Read more and read the study abstract.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares